My new blog at MedPage Today started: Third Opinion! Here's my first post:

Knee Injections: Just a $1000 Placebo?  (And a related comment on PubMed Commons. I was also frustrated by a report of a trial on varenicline for smoking cessation.)

At PLOS Blogs, I hunted out websites that can reduce anxiety and depression.

Meanwhile, over at Statistically Funny, they were playing outcome mash-up: all about composite endpoints in clinical trials.

And added to Tumblr were: Studies of cave paintings have shown....; Wokka, wokka, wokka! (Pitfalls in science communication); Look, Ma! (A teachable moment) - and Jacinta's fortune teller.

Cartoon of Jacinta and the fortune teller

Women are really losing out at many science conferences. There’s a lot we can do to tackle the internal and external barriers, though. My latest at PLOS Blogs.

Cartoon of woman




Why don't we hear more women's voices in scientific discourse? It's not only because men tend to have the numbers: they tend to take up more space, too. Girls keep more diaries. As teenagers, they blog more. But women scientists seem to publish less, to blog less - even to peer review less. What does that mean for them, for the quality of scientific discourse - and what can we do about it? My latest at PLOS Blogs:


Andrew Maynard from the University of Michigan's Risk Science Center, wrote a post called, Social media and science communication: What are your benchmarks of success? If you're a blogger (or thinking about blogging), he's tackling the important issue of "why?" And I responded to his questions, here: For what it's worth...science communication that matters.

At PLOS Medicine: A research report or idea needs to clamber over more than the hurdle of publication to move science, practice, or policy forward. It's not only a matter of authors waiting for kudos and citations to roll in. If their work is not to sink into oblivion, or be acted on when it shouldn't be, publication is just the beginning...

Find me on: